[Platelet aggregation model in vivo (rabbits)].
The purpose of this study was to establish a blood platelet aggregation model that would permit "in vivo" (New Zealand rabbits) evaluation of hemodynamic and microscopic parameters. The platelet aggregation was induced by the administration of collagen I.V. 75 micrograms/kg/min, which produced a decrease of systolic arterial pressure from mean = 69 to mean = 55 mm Hg and diastolic pressure from mean = 43 to mean = 27 mm Hg, with ventricular increase from mean = 25 to mean = 41 mm Hg. Aspirin, dypiridamol or sulfinpyrazone was administered 10 mg/kg, half hour before the administration of collagen and prostacycline 100 mg/kg/min starting 3 minutes before until 10 minutes after the collagen injection. With the joint administration of collagen and aspirin, collagen and dypiridamol both systolic and diastolic arterial pressure were lowered with no modification in the ventricular values. No hemodynamic changes were observed with the joint administration of sulfinpyrazone-collagen or prostacycline-collagen. Histology demonstrated multiple vascular lung thrombosis with the administration of collagen and in less intensity when jointly administered with an antiaggregant drug. This model permits to measure hemodynamically and histologically pro and antiaggregant substances.
Facultad de Medicina, Departamento de Bioquímica y Farmacología, Universidad Autónoma de Coahuila.
J J
JJ
García Salcedo
A
A
Leal de Carrera
J L
JL
Amezcua
L B
LB
Serrano Gallardo
M A
MA
Rivera Guillén
M F
MF
Sanmiguel Salazar
D000818:Animals; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008954:Models, Biological; D009206:Myocardium / Q000473:pathology; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits
Modelo de agregación plaquetaria in vivo (conejos).